secwatch / observer
8-K filed February 13, 2025, 6:59 PM ET ticker IBRX CIK 0001326110
other material confidence high sentiment neutral materiality 0.50

ImmunityBio approves executive compensation: 2024 bonuses, 2025 equity grants, salary increases

ImmunityBio, Inc.

ImmunityBio, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-25-025324
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.